Journal profile · CELL BIOLOGY-NEUROSCIENCES
Neural Regeneration Research
ISSN 1673-5374 · eISSN 1876-7958 · Wolters Kluwer Medknow Publications · PEOPLES R CHINA · Monthly · Founded 2006
Neural Regeneration Research: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 8.4; JCR Q1 (journal website); fully open access; APC about USD 2,500; median 113 days to acceptance (97 articles, last 24 months); community-reported acceptance: about 70.71%; 473 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Neural Regeneration Research is published by Wolters Kluwer Medknow Publications and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Nerve injury and regeneration, Neuroinflammation and Neurodegeneration Mechanisms and Neurogenesis and neuroplasticity mechanisms, together about 35.4% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Neural Regeneration Research (NRR) is the Open Access journal specializing in neural regeneration and indexed by SCI-E and PubMed. The journal is committed to publishing articles on basic pathobiology of injury, repair and protection to the nervous system, while considering preclinical and clinical trials targeted at improving traumatically injuried patients and patients with neurodegenerative diseases.
Source: LetPub
Research area (LetPub): CELL BIOLOGY-NEUROSCIENCES
Editor-in-chief Kwok-fai SoPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nerve injury and regenerationNeuroscience14%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience11.1%
- Neurogenesis and neuroplasticity mechanismsNeuroscience10.2%
- Alzheimer's disease research and treatmentsMedicine7.3%
- Spinal Cord Injury ResearchMedicine6.7%
- Neuroscience and Neuropharmacology ResearchNeuroscience4.4%
- Parkinson's Disease Mechanisms and TreatmentsMedicine3.9%
- Traumatic Brain Injury and Neurovascular DisturbancesMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 2 |
| Minor | Neurosciences | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 2 |
| Minor | Neurosciences | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 3 |
| Minor | Neurosciences | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · CELL BIOLOGY · rank 35/207
- JCR Q1 · NEUROSCIENCES · rank 20/330
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.4LetPub ·
- Impact factor (publisher)
- 8.5Publisher website ·
- CiteScore 2026-06
- 11.1LetPub ·
- SJR 2026-06
- 1.43LetPub ·
- SNIP 2026-06
- 1.09LetPub ·
- h-index
- 24LetPub ·
- h-index
- 101OpenAlex ·
- i10-index
- 3,180OpenAlex ·
- 2-year mean citedness
- 5.45OpenAlex ·
- Self-citation rate
- 11.8%LetPub ·
- Share of gold OA articles
- 98.77%LetPub ·
Volume
- Articles per year
- 298LetPub ·
Articles by year OpenAlex count · 6,182 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 246 | 246 | 73 |
| 2025 | 473 | 473 | 1,815 |
| 2024 | 518 | 518 | 4,854 |
| 2023 | 575 | 575 | 8,854 |
| 2022 | 542 | 542 | 10,356 |
| 2021 | 556 | 556 | 11,835 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
113 daysMedian, submission to acceptance · P25–P75 86 days – 155 days
- Acceptance to online
- median 42 days (97 articles)
- Submission to online
- median 168 days
- Sample
- 97 articles with submission and acceptance dates (853 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 70.71%LetPub ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,500 / CNY 19,800 | Yes | CC BY-NC-SA | |
| OpenAlex | USD 1,500 | — | — | |
| LetPub | USD 1,500 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Medknow Publications
- Country or region
- PEOPLES R CHINA
- Language
- English
- Frequency
- Monthly
- Founded
- 2006
- ISSN
- 1673-5374
- Electronic ISSN
- 1876-7958
- Latest issue on the website
- Volume 21, Issue 11 (November 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Neural Regeneration Research
What CAS zone is Neural Regeneration Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Neural Regeneration Research is in Zone 2 of Medicine, and in Zone 2 of the minor category Cell Biology / Neurosciences. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Neural Regeneration Research?
The latest impact factor listed by LetPub is 8.4; CiteScore 11.1, h-index 101.
How long does peer review take at Neural Regeneration Research?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 113 days (interquartile range 86–155 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 70.71%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Neural Regeneration Research in?
The journal's website gives JCR Q1; by category, CELL BIOLOGY Q1 (35/207), NEUROSCIENCES Q1 (20/330). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Medicine.
Which databases index Neural Regeneration Research?
According to LetPub and DOAJ records, Neural Regeneration Research is indexed in SCIE, Scopus and DOAJ.
Is Neural Regeneration Research open access, and what is the APC?
Neural Regeneration Research is a fully open-access journal. APC about USD 2,500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .